Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
Background: Cilostazol is a type 3 phosphodiesterase inhibitor which has been previously demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation efficacy. However, the mechanism for this beneficial effect is still unclear. Since cardiac mitochondria have been shown to pl...
Saved in:
Main Authors: | Siriporn C. Chattipakorn, Savitree Thummasorn, Jantira Sanit, Nipon Chattipakorn |
---|---|
格式: | 雜誌 |
出版: |
2018
|
主題: | |
在線閱讀: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84904509817&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/53775 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
由: Siriporn C. Chattipakorn, et al.
出版: (2018) -
Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
由: Chattipakorn S.C., et al.
出版: (2014) -
Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
由: Chattipakorn S.C., et al.
出版: (2014) -
Granulocyte-colony stimulating factor attenuates mitochondrial dysfunction induced by oxidative stress in cardiac mitochondria
由: Savitree Thummasorn, et al.
出版: (2018) -
Effects of cilostazol in the heart
由: Natnicha Kanlop, et al.
出版: (2018)